NIH PRIMED-AI Program Offers 5 Funding Opportunities to Develop Personalized Medicine AI Tools for Chronic Diseases, Deadline October

July 19, 2026

National Institutes of Health (NIH) USA

Overview

The National Institutes of Health (NIH) has announced five funding opportunities through its Common Fund PRIMED-AI program to develop innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with other health data types. Aimed at enhancing personalized medicine for patients with chronic and other health conditions, the program seeks centers to undertake roles such as validation, logistics, and framework development. With an October application deadline, this initiative drives crucial research investment in medical AI.

In Depth

Key Findings

The National Institutes of Health (NIH), through its Common Fund PRIMED-AI program, has announced five funding opportunities aimed at developing innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with various other health data types. This program seeks to significantly enhance personalized medicine for patients suffering from chronic diseases and other health conditions.

Technical Details

The PRIMED-AI (likely ‘Precision Medicine in Diverse Populations through AI’) program focuses on the following key areas:

Data Integration and AI Tool Development: Supports the development of AI tools capable of seamlessly integrating clinical imaging data (e.g., MRI, CT, X-ray) with other health data types, such as genomic data, electronic health records (EHRs), and wearable device data. This aims to build comprehensive patient health profiles, enabling more personalized diagnostics and treatment plans.
Enhancing Personalized Medicine: Leverages AI, particularly for the management of chronic diseases (e.g., heart disease, diabetes, cancer) and health conditions in diverse populations, to promote individualized medical approaches based on each patient’s genetic, environmental, and lifestyle characteristics.
Reliability and Cost-Effectiveness: The AI tools developed must demonstrate high accuracy and robustness, be reliable for clinical use, and improve the overall cost-efficiency of the healthcare system.
Roles Sought: The program specifically welcomes applications from centers responsible for AI tool validation, management and logistics of large datasets, and the development of broad AI frameworks. This aims to build infrastructure supporting the practical application and scaling of research outcomes.

The application deadline in October marks a significant opportunity to foster the next breakthroughs in medical AI.

Background & Context

Personalized medicine holds immense promise for delivering optimal treatment to each individual patient, but it necessitates the ability to integrate and analyze vast amounts of heterogeneous medical data. While traditional analytical methods faced limitations, advancements in AI and machine learning offer powerful tools to overcome this challenge. The concentrated investment by major funding bodies like the NIH in medical AI indicates that this field is reaching a critical stage of academic and clinical maturity, poised for practical implementation. Chronic diseases, in particular, represent a major global public health challenge, and personalized AI tools have the potential to dramatically improve patients’ quality of life through earlier diagnosis, precise treatment, and optimized preventive measures.

Strategic Significance & Outlook

The NIH’s PRIMED-AI program will accelerate progress in medical AI research and serve as a crucial step toward realizing personalized medicine. Awarded projects are expected to generate new insights and tools for integrating AI technology into clinical practice, contributing to the standardization of medical data integration and the development of AI model validation frameworks. In the long term, this is anticipated to enable physicians to make more accurate diagnoses and patients to receive more effective treatments, thereby improving healthcare outcomes. Furthermore, if the cost-effectiveness of AI tools is demonstrated, it will contribute to increased efficiency and accessibility across the entire healthcare system, ultimately building a foundation for providing equitable personalized medicine to diverse patient populations.

Source: https://www.sirweb.org/publications/news/apply-to-the-nih-common-fund-primed-ai-funding-opportunities/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.